# Heying Capital

> Heying Capital is a VC fund in Tianjin backing Medical and Health Care. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tianjin, China
- Total investments: 2
- Last investment: Feb 2025
- Lead investor: 50%
- Last updated: Aug 2026
- Website: http://www.heying-capital.com/index.aspx

Heying Capital is a VC fund in Tianjin focused on Medical and Health Care. Heying Capital provide strong talent guarantee for the company's sustainable development.

## Contacts

5 contacts available for Heying Capital. Shizune tracks 1 team members at Heying Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/heying-capital-5ab0?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 1 | 50% |
| Series A | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Feng Zhihua | President | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neurodome | Neurodome is a manufacturer of non-invasive deep brain nerve modulation technology. It focuses on the research and development of non-invasive deep brain nerve modulation products. |  | Series A | Feb 24, 2025 |  |
| Delifery | Delifrui Pharmaceuticals is a developer of generic and innovative drugs, dedicated to the research, development and industrialization of high-end generic drugs and improved new drugs. |  | Angel |  |  |

2 of 2 investments shown.

## Co-investors
- [Beijing Huafang Investment](https://shizune.co/investors/profile/beijing-huafang-investment) — VC Fund, 1 deal together
- Xunfei Venture Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

## FAQ

### What does Heying Capital invest in?

Heying Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Angel and Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Heying Capital?

Public channels for Heying Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Heying Capital?

The team at Heying Capital includes Feng Zhihua (President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co